Idrx

About:

Idrx is a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment.

Top Investors: Andreessen Horowitz, RA Capital Management, Commodore Capital, Blackstone Group, Casdin Capital

Description:

IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies. IDRx is headquartered in Plymouth, Massachusetts and was founded in 2022.

Total Funding Amount:

$242M

Headquarters Location:

Plymouth, Massachusetts, United States

Founded Date:

2022-01-01

Contact Email:

info(AT)Idrx.com

Founders:

Alexis Borisy, Ben Auspitz, George Demetri, Nick Lydon, Robert Forrester

Number of Employees:

11-50

Last Funding Date:

2024-08-07

IPO Status:

Private

Industries: